Related Experiment Videos
Amyloid neuropathy in light chain multiple myeloma
A Schenone1, A Primavera, I De Martini
1Institute of Clinical Neurology, University of Genoa, Italy.
Clinical Neuropathology
|May 1, 1989
Summary
Peripheral neuropathy can be caused by amyloidosis in patients with light chain multiple myeloma. This case highlights amyloid deposits in peripheral nerves, emphasizing their role in myeloma-related neuropathy.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Peripheral neuropathy is a common complication of multiple myeloma.
- Light chain multiple myeloma is a plasma cell dyscrasia characterized by the overproduction of monoclonal immunoglobulin light chains.
Observation:
- A 73-year-old man presented with symptoms of peripheral neuropathy.
- Diagnostic workup revealed light chain lambda-type multiple myeloma.
- A sural nerve biopsy was performed to investigate the neuropathy.
Findings:
- The sural nerve biopsy demonstrated the characteristic neuropathological features of amyloid neuropathy.
- Amyloid deposits were identified within the peripheral nerves of the patient.
- This finding represents the first documented instance of amyloid deposition in peripheral nerves associated with light chain multiple myeloma.
Implications:
- Amyloidosis is a significant factor in the pathogenesis of peripheral neuropathy in light chain multiple myeloma.
- Early recognition and diagnosis of amyloid neuropathy are crucial for effective patient management.
- Further research into the mechanisms of amyloid deposition in myeloma is warranted.